Position in ARGX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$207,391
-$40,689 QoQ
Shares Held
284
-3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ashton Thomas Private Wealth, LLC holds $8,478,289 across 12 Biotechnology names. ARGX ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
33,597 | $3,162,149 | |
| 2 | EXEL |
Exelixis, Inc.
|
26,638 | $1,142,503 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,556 | $1,141,356 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
15,234 | $984,573 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
38,292 | $948,109 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
2,194 | $438,032 | |
| 7 | ARGX |
Argenx SE
This page
|
284 | $207,391 | |
| 8 | NAUT |
Nautilus Biotechnology, Inc.
|
45,000 | $174,600 |
All Filings in ARGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $207,391 | 284 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $248,080 | 295 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||